Home > Author

Blog Posts by Author: Adam Ortlieb

Part 3: Analytics for the Lab Director

This is the third installment of a four-part series. View Part One or Part 2 (Analytics for the RCM Team). Hospital financials have partially rebounded from a difficult start in 2022, but operating margins remained at a loss in March, for the third consecutive month. Meanwhile, hospitals continue to focus on improving the patient experience. Laboratory outreach and outpatient operations can...

Read


Part 2: Analytics for the RCM Team

This blog post is the second installment of a four-part series. View Part One Profitability and patient satisfaction targets remain elusive for hospitals in 2022, but laboratory outreach and outpatient operations can contribute to these larger organizational goals with the appropriate people, processes, and technologies in place. This second installment of our “How to Calibrate Hospital Lab...

Read


How to Calibrate Hospital Lab Financial Performance, Part 1

Hospitals face fundamental challenges relative to financial targets and patient experience goals. When prioritizing and evaluating lab financial performance, it is fitting to consider tactical revenue cycle management (RCM) decisions in the broader context of these strategic financial and operational hurdles.Historically, the lab has often been seen as a cost center, solely focused on supporting...

Read


XIFIN Acquisition Opens Opportunities for Diagnostics Providers, Targets Patient-Centric Care

XIFIN recently announced the acquisition of OmniSYS, a healthcare technology company that serves more than 30,000 pharmacies, including four out of the top five national chains. OmniSYS capabilities include patient engagement, medical claims processing, automated pricing, managing clinical workflow, and supporting new clinical services such as immunizations, medication management, point-of-care...

Read


Mitigating Hospital Margin Challenges in 2022

A shortage of nurses and other workers will continue to weaken the financial performance of for-profit and not-for-profit hospitals in 2022, according to the latest Moody’s Healthcare Quarterly. “The sharp rise in COVID-19 cases in various regions of the US has contributed to a wave of nurses, often burned out, resigning to take care of family, work in less acute healthcare settings such as...

Read


Providers Rate XIFIN 1st in Lab Support and RCM Outsourcing, a Clean Sweep for Overall, Hospital, Diagnostic, and Pathology Categories

The results are in for the industry’s premier independent analysis of revenue cycle management (RCM) vendors and XIFIN is the clear winner. The Black Book Research 2021 Laboratory Support and Revenue Cycle Management Outsourcing report ranks 20 RCM vendors on 18 critical performance criteria, based on validated survey results from 1,570 users. XIFIN earned top scores for overall mean, 10...

Read


Delta Variant Impact on Lab Testing Volumes

The impact of the SARS-CoV-2 Delta variant is increasingly severe. The CDC has determined this strain is nearly twice as contagious as previous variants and two studies indicate Delta patients are more likely to be hospitalized than those infected with Alpha or the original virus strains.1 97.4% of all U.S. COVID-19 cases stem from this variant.2Infection numbers are rising rapidly. On August 11...

Read


Ensuring Oncology Practice Compliance with the No Surprises Act

The adverse impacts of surprise billing have garnered significant national attention, culminating in rare bi-partisan supported legislation that directly impacts community oncology practices. The No Surprises Act was signed into law as part of the Consolidated Appropriations Act of 2021.Surprise billing occurs when patients unknowingly receive either emergency or non-emergency care from an out-of...

Read